en · de · es · pt
analytical-notes.peptides4088.com › Guide › Background And Molecular Identity — Explained

Background And Molecular Identity — Explained

By Editorial Desk · published 2026-03-30 · last reviewed 2026-05-17 · Guide

Everything below concerns AOD-9604. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2026-05-17. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Molecular Identity

AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.

The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.

Mechanism And Metabolic Effects

Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.

Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.

A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideBased on the C-terminal region of human growth hormone.
Amino acid length16 residuesOften described as hGH fragment 176-191.
AppearanceLyophilized powderTypically white to off-white; exact appearance depends on grade.
SolubilitySoluble in waterAqueous solubility depends on pH, ionic strength, and preparation.
Typical storage-20 °C or lowerLyophilized peptide is usually kept cold and dry; solutions may require freezing.

Mechanism and Regulatory Status

Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.

Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.

Related pages on this site

Measurement and Storage Practices

Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.

Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.

Research and Regulatory Status

AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.

Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.

Regulation and Detection Context

AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.

Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.

Further detail

This infuriated American colonists and led to the Boston Tea Party, where 90,000 pounds of EIC tea were dumped into the Boston Harbor. As news spread, tea was destroyed throughout the colonies. In Greenwich New Jersey for example, chests of tea were burned in Market Square. As a consequence of these acts and the American revolution (1765–1791), tea drinking became seen as unpatriotic. One article in the Boston Gazette on 15 August, 1768 stated: “Let us abjure the poisonous baneful plant and its odious infusion – poisonous and odious, I mean, not on account of its physical qualities but on account of the political diseases and death that are connected with every particle of it.” Boycotts of tea by revolutionary patriots led to an increase in consumption of other beverages, such as coffee, yaupon tea, or herbal teas infused with peppermint, sage or dandelions. In spite of the distaste for tea that was fueled by the revolution, tea continued to be used by Americans, especially after the war. For example, George Washington regularly had tea for breakfast and dinner, in the English fashion. American merchants Samuel Shaw and Robert Morris sent the first merchant ship to China (the Empress of China) and soon Chinese tea was being shipped to America by American merchant vessels.

Aurélia Nguyen is a French-Vietnamese public health official, and the current Deputy Chief Executive Officer of CEPI (Coalition for Epidemic Preparedness Innovations)[1]. She previously was the managing director of the COVAX Facility at Gavi (formerly Global Alliance for Vaccines and Immunization.). In her role at COVAX, she works on providing COVID-19 vaccines to lower income countries, and tackling issues such as vaccine diplomacy, exports controls, limited supplies and cold-chain logistics.

=== Other proteins === Zinc serves a purely structural role in zinc fingers, twists and clusters. Zinc fingers form parts of some transcription factors, which are proteins that recognize DNA base sequences during the replication and transcription of DNA. Each of the nine or ten Zn2+ ions in a zinc finger helps maintain the finger's structure by coordinately binding to four amino acids in the transcription factor. In blood plasma, zinc is bound to and transported by albumin (60%, low-affinity) and transferrin (10%). Because transferrin also transports iron, excessive iron reduces zinc absorption, and vice versa. A similar antagonism exists with copper. The concentration of zinc in blood plasma stays relatively constant regardless of zinc intake. Cells in the salivary gland, prostate, immune system, and intestine use zinc signaling to communicate with other cells. Zinc may be held in metallothionein reserves within microorganisms or in the intestines or liver of animals. Metallothionein in intestinal cells is capable of adjusting absorption of zinc by 15–40%. However, inadequate or excessive zinc intake can be harmful; excess zinc particularly impairs copper absorption because metallothionein absorbs both metals. The human dopamine transporter contains a high affinity extracellular zinc binding site which, upon zinc binding, inhibits dopamine reuptake and amplifies amphetamine-induced dopamine efflux in vitro. The human serotonin transporter and norepinephrine transporter do not contain zinc binding sites.

Sources: en.wikipedia.org

Supporting material

In 2000, Wesley Enoch wrote and directed a modern adaptation titled Black Medea, which was first produced by Sydney Theatre Company's Blueprint at the Wharf 2 Theatre, Sydney, on 19 August 2000. Nathan Ramsay played the part of Jason, Tessa Rose played Medea, and Justine Saunders played the Chorus. Medea is re-characterised as an indigenous woman transported from her homeland to the city and about to be abandoned by her abusive social-climbing husband. Tom Lanoye (2001) used the story of Medea to bring up modern problems (such as migration and man vs. woman), resulting in a modernized version of Medea. His version also aims to analyze ideas such as the love that develops from the initial passion, problems in the marriage, and the "final hour" of the love between Jason and Medea. Roger Kirby's 2004 adaptation of the play, Medea in Jerusalem, was set in modern day Israel, and featured an Israeli-Jewish Jason and a Palestinian Medea who opts to turn her children into suicide bombers after being divorced by Jason. It premiered at the Rattlestick Playwrights Theatre in New York City. Kristina Leach adapted the story for her play The Medea Project, which had its world premiere at the Hunger Artists Theatre Company in 2004 and placed the story in a modern-day setting. Peter Stein directed Medea in Epidaurus 2005. Irish playwright Marina Carr's By the Bog of Cats is a modern re-telling of Euripides' Medea. In November 2008, Theatre Arcadia, under the direction of Katerina Paliou, staged Medea at the Bibliotheca Alexandrina (University of Alexandria, Egypt).

A December 2024 report by Amnesty International found the use of unguided missiles on civilian areas to likely constitute indiscriminate attacks. International humanitarian law states that parties in a conflict must not direct attacks at civilians and must distinguish civilians and civilian infrastructure from military targets.

Authorities in Italy have investigated a 'Ndrangheta mafia clan accused of trafficking and illegally dumping nuclear waste. According to a whistleblower, a manager of the Italy state energy research agency Enea paid the clan to get rid of 600 drums of toxic and radioactive waste from Italy, Switzerland, France, Germany, and the United States, with Somalia as the destination, where the waste was buried after buying off local politicians. Former employees of Enea are suspected of paying the criminals to take waste off their hands in the 1980s and 1990s. Shipments to Somalia continued into the 1990s, while the 'Ndrangheta clan also blew up shiploads of waste, including radioactive hospital waste, sending them to the sea bed off the Calabrian coast. According to the environmental group Legambiente, former members of the 'Ndrangheta have said that they were paid to sink ships with radioactive material for the last 20 years. In 2008, Afghan authorities accused Pakistan of illegally dumping nuclear waste in the southern parts of Afghanistan when the Taliban were in power between 1996 and 2001. The Pakistani government denied the allegation.

Sources: en.wikipedia.org

Supporting material

=== Pro-101-1 (thermal burns) === Pro-101-1 is a topical PDGF-BB gel candidate for the treatment of thermal burns. The company received approval from China's National Medical Products Administration (NMPA) to commence Phase IIa clinical trials in June 2022, which were completed in May 2023. The Phase IIb clinical trial reached last patient out in April 2025, and the clinical report for deep second-degree burns was finalised in December 2025. As of May 2026, Pro-101-1 had enrolled the first patient in its Phase IIIa clinical trial for deep second-degree burns in China. The U.S. FDA has confirmed that Pro-101-1 is eligible for approval via the Section 351(a) biologics BLA pathway.

== Fictional spy stories == Cloak and dagger stories became part of the popular culture of the Cold War in both East and West, with innumerable novels and movies that showed how polarized and dangerous the world was. Soviet audiences were thrilled by spy stories showing how their KGB agents protected the motherland by foiling dirty work by the intelligence agencies of the United States, United Kingdom, and Israel. After 1963, Hollywood increasingly depicted the CIA as clowns (as in the comedy TV series Get Smart) or villains (as in Oliver Stone's 1992 film JFK). Ian Fleming's infamous spy novels about the MI6 agent James Bond also referenced elements of the Cold War when being adapted into films. One example of this includes the first Bond film, Dr. No, which was released in 1962 and used the Cuban Missile Crisis as a plot base. However, Cuba was substituted for Jamaica in the film.

Within maritime environments one of the largest pest threats to waterlogged wood includes shipworms (Teredinidae). Shipworms bore into wood that is immersed in seawater. Within a museum exhibit or storage environment and post treatment of waterlogged wood objects, there are a number of wood-boring pests that feast on wood. Two of which include the wood-boring/powderpost beetle and termites. Wood-boring beetles can include several different types within the board category. Each type of beetle could target a different type of wood. Evidence of pest deterioration includes powder-like frass near entry and exit holes within the wood. Termites also feast on and live below the surface of the wood so they can be more difficult to detect. Termites discharge six-sided fecal pellets and, if found on a wooden object, could be used to determine the type of pest damage

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.

Is AOD-9604 the same as human growth hormone?

No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.

Does AOD-9604 occur naturally?

The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.

How is AOD-9604 thought to work?

It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.

Network